Opus Genetics (IRD) FCF Margin (2020 - 2026)

Opus Genetics (IRD) reported FCF Margin of 590.03% for Q1 2026, down 38422.0% year-over-year from N/an in Q1 2025, and down 131.92% quarter-over-quarter from 254.41% in Q4 2025.

Opus Genetics (IRD) FCF Margin (2020 - 2026) Analysis & Trends

Opus Genetics (IRD) has 7 years of FCF Margin data on file, last reported at 590.03% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 590.03%, down 38422.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 325.34% (down 11398.0% YoY), and the FY2025 annual result was 248.33%, down 1565.0% from the prior year.
  • FCF Margin fell to 590.03% in Q1 2026 per IRD's latest filing, from 254.41% in the prior quarter.
  • Over five years, FCF Margin peaked at 268.95% in Q4 2023 and troughed at 655.76% in Q2 2024.
  • A 5-year average of 197.67% and a median of 202.89% in 2025 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2024 and 2025: FCF Margin slumped 68267 bps in 2024, then soared 29944 bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 72.25% in 2022, then surged by 272 bps to 268.95% in 2023, then tumbled by 164 bps to 172.9% in 2024, then sank by 47 bps to 254.41% in 2025, then sank by 132 bps to 590.03% in 2026.
  • Business Quant data shows IRD's FCF Margin at 590.03% in Q1 2026, 254.41% in Q4 2025, and 199.97% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Opus Genetics 355.39 Mn 295.43 Mn - -590.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 -590.03%
Dec 31, 2025 -254.41%
Sep 30, 2025 -199.97%
Jun 30, 2025 -356.32%
Mar 31, 2025 -205.81%
Dec 31, 2024 -172.90%
Sep 30, 2024 -132.66%
Jun 30, 2024 -655.76%
Mar 31, 2024 -334.07%
Dec 31, 2023 268.95%
Sep 30, 2023 -25.16%
Jun 30, 2023 26.92%
Mar 31, 2023 -208.46%
Dec 31, 2022 72.25%
Sep 30, 2021 -732.92%
Jun 30, 2021 -4,328.00%
Mar 31, 2020 -63.65%